SINOPHARM GRP CO. H YC 1 earnings per share and revenue

X2S earnings per share for the last semiannual are 0.20 EUR whereas the estimation was 0.19 EUR which accounts for 5.30% surprise. Företagets omsättning för samma period uppgår till 37.72 B EUR trots den uppskattade siffran 40.00 B EUR. Estimated earnings per share for the next semiannual are 0.18 EUR, and revenue is expected to reach 40.04 B EUR. Also watch annual changes over time to get a bigger picture of X2S earnings per share and revenue dynamics.